CryoLife, Inc. Says Medafor, Inc. Rejects its $2/Share Offer

Bookmark and Share

Reuters -- CryoLife Inc, a maker of implantable devices, said it would consider commencing a tender offer or a proxy contest for Medafor Inc after the privately held company rejected its $2 per share offer.

MORE ON THIS TOPIC